THE ASSOCIATION OF CLINICAL SCIENTISTS
Assess trainees as a preliminary to HCPC registrationPromote, advance & encourage the study & practice of the application of science in the prevention, diagnosis & control of illness & disabilityEstablish, uphold and improve qualification, training, competence & conduct of UK Clinical ScientistsWork & liaise with relevant professional bodies,including HCPC on matters relating to the above
Financial health, per its FY2024 accounts
The accounts state that unrestricted reserves stood at £51,114, which the trustees consider sufficient to cover operational expenditure for up to 1 year and 11 months against a policy target of six months. The charity reported a net income of £5,205 for the year and is subject to independent examination rather than audit.
What the accounts disclose
“The trustees consider the ideal level of reserves to be sufficient to cover six months of its annual expenditure. At the year end, reserves (all unrestricted) stood at £51,114 (2023: £45,909). Based on 2024 expenditure, this would cover operational expenditure for up to 1 year and 11 months and thus is considered to be sufficient.” — page 5
Trustees
- Dr Jacob Vaarkampchair
- April Sellors
- DR Ross Stuart Sadler
- Dr Katherine Elizabeth Templeton
- Dr Michelle Rebecca Foster
- Dr Olivia Jane Shaw
- Dr Sylvia Sharon Armstrong-Fisher
- Jason Kasraie
- Katharine Elizabeth Hayden
- Professor Malcolmn Sperrin
- Victoria Jane Stinton
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £31k | £26k |
| 31/12/2023 | £33k | £24k |
| 31/12/2022 | £33k | £30k |
| 31/12/2021 | £29k | £19k |
| 31/12/2020 | £33k | £37k |
Common questions
Is THE ASSOCIATION OF CLINICAL SCIENTISTS financially healthy?
Per its FY2024 accounts: The accounts state that unrestricted reserves stood at £51,114, which the trustees consider sufficient to cover operational expenditure for up to 1 year and 11 months against a policy target of six months. The charity reported a net income of £5,205 for the year and is subject to independent examination rather than audit. Its FY2024 accounts were independently examined.